Statistics for A Src/Abl kinase inhibitor, bosutinib, downregulates and inhibits PARP enzyme and sensitizes cells to the DNA damaging agents

Total visits

views
A Src/Abl kinase inhibitor, bosutinib, downregulates and inhibits PARP enzyme and sensitizes cells to the DNA damaging agents 2

Total visits per month

views
February 2024 0
March 2024 0
April 2024 0
May 2024 0
June 2024 0
July 2024 0
August 2024 0

File Visits

views
Tepedelen_vd_2018.pdf 2